| Revenue growth | Standalone +11% QoQ, ~12.5% YoY; consolidated +23% YoY, volume ~10%, price 13% |
|---|---|
| Margins | Standalone EBITDA 36%, PAT 24%; compressed by raw-material inflation, pass-through failed. |
| Demand visibility | Demand steady; customer demand resilient despite cost pressure. |
| Management confidence | Balanced; cautious on margins, bullish on HALS and PC2. |
Growth
Standalone revenue ₹226 Cr, +11% QoQ, ~12.5% YoY, QoQ volume-led and YoY realisation-led. Consolidated revenue ₹295 Cr, +23% YoY.
Outlook
PC2 commercial production Q3–Q4 FY27. HALS utilisation at 30–35%, targeted at 55–60% in coming quarters. HALS capacity rising to 12,500 t.
Risks
Raw material costs up 50–100% YoY, with Chinese prices held low, blocking pass-through. One planned product project is on hold.
Last quarter's promises, checked
Partly delivered
- Guided PC2 commercialised by Q3 FY27 → now Q3–Q4 FY27 (= PARTIAL)
- Guided HALS FY27 revenue ₹250–300 Cr annualised → HALS revenue 'doubled YoY', no ₹ figure (= PARTIAL)
Missed
- Guided EBITDA margins to keep improving from 43% → delivered 36% (= MISS)
Earnings Call Transcript filed with NSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹715.60
- Market cap
- ₹7,606 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.6×Sector 34.1×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.
Clean Science & Technology Legal & Regulatory
Clean Science concluded GST proceedings, resulting in a ₹2.0 crore net financial impact. A further ₹9.9 crore liability is recoverable as Input Tax Credit.
- Value
- ₹11.90 Cr